Tags » Whitepapers

Rethinking Innovation and Design for Emerging Markets

Abstract

Book Title:     Rethinking Innovation and Design For Emerging Markets: Inside the Renault Kwid Project
Author:  Christophe Midler, Bernard Jullien, Yannick Lung
Publisher:  Auerbach Publications… 129 more words

Whitepapers

Trinity Partners Reveals Findings on FDA-Approved Novel Drug Performance

Trinity Partners, a leading global life sciences consulting firm, today announced the findings of its second annual Trinity Drug Index which assessed all novel drugs approved by the FDA in 2014. 275 more words

News

Trinity Partners Launches New Whitepaper to Assess Value in Ultra-Orphan Markets

Trinity Partners, a leading global life sciences consulting firm, today announced, at the NORD Rare Disease and Orphan Products Breakthrough Summit in Washington, D.C., a new whitepaper titled ‘Assessing Value in Ultra-Orphan Markets’. 441 more words

News

Under-Spend: An Earned Value Analysis of 60 Projects in the Sahel

Abstract

Earned Value Management (EVM) is a rigorous and widely used analysis technique that provides valuable information about projects’ costs and schedules. A brief introduction is provided in this paper. 165 more words

Whitepapers

Overview of Content Marketing

Content marketing being, one of the most crucial streams of marketing is the process of creating and distributing relevant content to attract, persuade and engage our audience. 469 more words

Digital Marketing

5 Retirement Mistakes Small-Business Owners Make and How to Avoid Them

As a business owner, you face unique challenges and opportunities when building your financial future. This special report provides insights on mistakes to avoid and steps to take for building the retirement you desire—while managing your myriad responsibilities. 2,314 more words

Trinity Partners Identifies Value Proposition of Most Expensive Drugs Approved by the FDA from 2014-2016

Trinity Partners today, in tandem with the 22nd Annual International ISPOR Meeting, announced the results of a whitepaper titled, “What We Value: The Proposition Behind the Price.” The authors analyze the costliest drugs to the healthcare system approved by the FDA from 2014-2016 in order to understand the interaction between value and price.  61 more words